Psychedelic Research News

Germany’s Psilocybin Compassionate‑Use Program: Europe’s First for Treatment‑Resistant Depression

Germany has taken a historic step by permitting psychiatrists to prescribe psilocybin for treatment‑resistant depression under a compassionate‑use framework. This marks the first time a European Union country has given doctors authority to administer the psychedelic compound outside of clinical trials. The Central Institute of Mental Health (CIMH) in Mannheim and Berlin’s OVID Clinic, both...

Reflecting on PS2025: MAPS Psychedelic Science Conference

As we reflect on our incredible weekend in Denver, we feel uplifted, inspired, and energized for the future. Exhibiting with both of our organizations—our research and manufacturing hub, The Bunk Police, and our nonprofit organization, Transparency—felt like a rewarding, comprehensive showcase of everything we’ve achieved to get to this moment. This mission is often...

How Much Do You Know About the CIA’s MK-ULTRA?

MK-ULTRA is a corner of U.S. history so covert it almost went unnoticed, and so dark it’s still barely believable. Known as “the most sustained search in history for techniques of mind control,” MK-ULTRA became infamous for its questionable ethical standards and unorthodox methodology—namely, radical experiments involving high doses of LSD. For years, the CIA...